Key facts
- Notable investors include Darae, Posco IMP.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Fint Korea
- ·The full record, as it builds
Funding rounds
No funding rounds for Fint Korea are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Fint Korea
Manufacturer of biodegradable medical composite material based on biopolymers designed to reduce environmental impact. The company offers degradable cardiovascular stent, medical micro needles, cosmetic micro needle, absorbable hemostatic products for internal use, enabling its clients to have environmental friendly medical supplies.
- Sector
- Healthcare
- HQ
- Gwangju, South Korea
- Founded
- 2021
- Employees
- 11
- Website
- fintkorea.com/
- Ownership
- Privately Held (backing)
Fint Korea doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Fint Korea shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Fint Korea in its N-PORT filings yet. We sweep new filings monthly.